We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

bit.bio Logo


bit.bio is an award-winning human synthetic biology company whose mission is to code cells for novel cures. They have developed an end-to-end platform for the creation of any human cell type. With their cutting-edge and patent-protected opti-ox precision cell programing technology, bit.bio can deterministically program human induced pluripotent stem cells (iPSCs) into a chosen cell identity with unprecedented biological consistency at an industrial scale and approximately 10 times faster than conventional methods. Their platform has the potential to unlock a new generation of medicines.

Latest bit.bio Content

iPSC-derived astrocytes, human astrocytes, glial cells, opti-ox technology

ioAstrocytes - Human iPSC-Derived Astrocytes

ioAstrocytes offer a solution to researchers who are searching for easy-to-use, highly characterised human cells that are designed for co-culture and effectively recapitulate astrocyte functions within CNS models in vitro

How To Accelerate Research and Drug Discovery in Motor Neuron Disease: A Deep Dive Into Precision Reprogrammed Human iPSC-Derived Motor Neurons

In the Teach Me in 10 video, Dr. Marcos Herrera-Vaquero, bit.bio discusses motor neurons and their critical role in Motor Neuron Diseases (MNDs) such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA).
Neuro Research
App Note / Case Study

Speeding Up Neuroscience Research

Delve into this case study to explore how a research lab at King’s College London used hiPSC-derived neurons to shed light on synaptic biology and potential treatments for psychiatric conditions.
bit.bio webinar technologynetworks 2nd May 2024

Uncovering the Glioma Microenvironment With In Vitro Neuronal Models

In this webinar, you’ll hear from Dr. Brian Gill about his research into neuron–glioma interactions and how they contribute to seizures and tumoral growth.
Innovations in Disease Modeling 2024
Online Event

Innovations in Disease Modeling 2024

Explore the tools and techniques being used to study diseases in the lab. Discover how advances in cell culture and disease modeling are supporting diagnostic and therapeutic development.
Amyloid plaques.
Industry Insight

The Pathology of Proteins: A Tangled Tale of Alzheimer's

Explore the current understanding from the scientific literature on how protein misfolding, mislocalization and malfunction can lead to Alzheimer's disease.
Teach Me in 10 image

Revolutionizing In Vitro Disease Models With iPSC Reprogramming Technology

In this Teach Me in 10, we are joined by Dr. Will Bernard to get a primer on the latest innovations in in vitro human cell technology.
Precision reprogramming iPSCs to generate a source of defined, scalable human cells

Precision Reprogramming iPSCs To Generate a Source of Defined, Scalable Human Cells

See how bit.bio's platform uses opti-ox technology to consistently convert stem cells into defined human cells.
Modeling Neurodegeneration

Discover a New Approach to Modeling Neurodegeneration

This poster demonstrates how a novel, precise and highly controlled iPSC reprogramming technology overcomes these limitations and enables the generation of mature cell types and isogenic models of neurodegenerative disease.

Optimized Human iPSC-Derived Sensory Neurons for Pain and Neuropathy Research

Many promising drugs which show efficacy in animal models have failed in the clinic due to interspecies variance in nociception mechanisms. Hence, consistent, scalable human in vitro models are required to accelerate potential therapeutics to the clinic.